Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Ambar Protein Industries Ltd

AMBARPIL
BSE
170.60
0.84%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Ambar Protein Industries Ltd

AMBARPIL
BSE
170.60
0.84%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
98Cr
Close
Close Price
170.60
Industry
Industry
Solvent Extraction
PE
Price To Earnings
13.89
PS
Price To Sales
0.20
Revenue
Revenue
482Cr
Rev Gr TTM
Revenue Growth TTM
25.65%
PAT Gr TTM
PAT Growth TTM
3.83%
Peer Comparison
How does AMBARPIL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
AMBARPIL
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
90936986909389112128117112125
Growth YoY
Revenue Growth YoY%
-0.610.5-9.4-9.7-0.5-0.229.630.442.826.025.511.7
Expenses
ExpensesCr
89916782909085107124115109122
Operating Profit
Operating ProfitCr
1324-13454223
OPM
OPM%
0.92.82.34.4-0.83.24.74.33.01.82.22.6
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
111111111101
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0213-12443123
Tax
TaxCr
0001-11111101
PAT
PATCr
011202332122
Growth YoY
PAT Growth YoY%
-100.6-6.069.651.5-2,150.036.5244.980.8651.1-56.4-25.6-35.8
NPM
NPM%
0.01.41.11.8-0.51.93.02.51.90.61.81.4
EPS
EPS
0.02.21.42.7-0.83.04.74.94.31.33.53.2

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
157168195206231284313340345337422482
Growth
Revenue Growth%
-2.07.415.95.511.923.310.28.41.6-2.325.014.2
Expenses
ExpensesCr
155167193203227278306330338330406470
Operating Profit
Operating ProfitCr
22334679771612
OPM
OPM%
1.11.21.31.51.72.12.42.72.12.23.72.4
Other Income
Other IncomeCr
101100011111
Interest Expense
Interest ExpenseCr
111113333222
Depreciation
DepreciationCr
000001111111
PBT
PBTCr
2123334644139
Tax
TaxCr
010112111132
PAT
PATCr
2122213433107
Growth
PAT Growth%
1,881.5-43.9176.3-10.5-5.6-38.7176.729.0-36.811.8206.8-27.1
NPM
NPM%
1.00.51.21.10.90.41.11.30.80.92.31.5
EPS
EPS
2.71.54.23.83.52.26.07.74.95.516.812.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
666666666666
Reserves
ReservesCr
-3-1024591316192932
Current Liabilities
Current LiabilitiesCr
91115183631293935343331
Non Current Liabilities
Non Current LiabilitiesCr
002588765332
Total Liabilities
Total LiabilitiesCr
131723315349506462617170
Current Assets
Current AssetsCr
81017193127294341414847
Non Current Assets
Non Current AssetsCr
576122222212122212223
Total Assets
Total AssetsCr
131723315349506462617170

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1-1-31131-3672
Investing Cash Flow
Investing Cash FlowCr
0-10-5-10-100000
Financing Cash Flow
Financing Cash FlowCr
-113670-22-6-7-2
Net Cash Flow
Net Cash FlowCr
0-111-21-10000
Free Cash Flow
Free Cash FlowCr
1-2-3-5-920-3561
CFO To PAT
CFO To PAT%
76.6-81.2-105.337.352.0243.431.9-56.8219.8221.522.5
CFO To EBITDA
CFO To EBITDA%
69.5-36.2-100.626.527.350.414.9-27.385.194.313.8

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
00000001712384117
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.03.843.826.612.1
Price To Sales
Price To Sales
0.00.00.00.00.00.00.00.10.40.30.3
Price To Book
Price To Book
0.00.00.00.00.00.00.00.95.63.33.4
EV To EBITDA
EV To EBITDA
1.72.73.34.86.04.03.55.220.814.69.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
10.69.98.89.04.34.24.45.44.85.76.2
OPM
OPM%
1.11.21.31.51.72.12.42.72.12.23.7
NPM
NPM%
1.00.51.21.10.90.41.11.30.80.92.3
ROCE
ROCE%
28.517.119.614.211.714.115.816.612.713.025.2
ROE
ROE%
55.217.241.827.220.411.123.623.312.812.627.8
ROA
ROA%
12.05.010.47.03.82.56.96.94.55.113.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Ambar Protein Industries Limited is an Ahmedabad-based manufacturer and trader specializing in the edible oil sector. Operating from a primary manufacturing facility in **Changodar, Gujarat**, the company leverages the state’s position as a leading processor of cotton to ensure a steady supply of raw materials. The company is currently undergoing a strategic transition, moving from standard oil refining toward a high-margin, health-conscious product portfolio while strengthening its balance sheet to achieve a **debt-free** status. --- ### **Core Manufacturing & Refining Capabilities** The company’s business model integrates the large-scale refining of crude oils with the strategic trading and packaging of diverse oil variants. It operates in a single business segment: **Manufacturing and selling of Edible Oil** (including Edible/Non-Edible Oils, Oil Cakes, and 'D' Oil Cakes). The refinery utilizes a sophisticated three-stage process to convert crude cottonseed oil into refined edible oil: 1. **Alkyl Refining:** Removal of impurities such as gums and fatty acids using phosphoric acid and caustic lye. 2. **Bleaching & Filtration:** Removal of coloring impurities using activated clay and carbon. 3. **Deodorization:** Distillation to remove odoriferous materials, followed by final filtration to ensure a neutral, high-quality end product. **Operational Volume (FY 2022-23):** * **Cottonseed Oil Refined:** **21,896.32 MT** * **Purchased & Packed Oil:** **1,807.84 MT** --- ### **Product Portfolio & Premiumization Strategy** Ambar Protein is pivoting its portfolio toward **high-quality, health-conscious** segments to address rising consumer demand for oils that mitigate risks of coronary heart disease and diabetes. | Segment | Product Category | Key Attributes | Status | | :--- | :--- | :--- | :--- | | **In-house Refined** | Cottonseed Oil | Core high-volume product | Active | | **Traded & Packed** | Groundnut, Sunflower, Maize, Soybean, Mustard | Diverse culinary applications | Active | | **Premium Oils** | **Cold Pressed Series** | Preserved nutrients, natural taste | **Trials started Feb 2025** | | **Health Oils** | Low Cholesterol/Balanced | Focus on **MUFA** and antioxidants | Core Market Focus | | **Specialty Fats** | Extra Virgin Coconut Oil | High antioxidant content | **New Launch** | **The Cold Pressed Initiative:** In **September 2024**, the Board approved the installation of specialized machinery for a new **Cold Pressed** line. Trials commenced on **February 10, 2025**. This line includes: * **Cold Pressed Groundnut Oil** * **Cold Pressed Extra Virgin Coconut Oil** * **Cold Pressed Sesame Oil** * **Cold Pressed Mustard Oil** --- ### **Financial Performance & Capital Structure** The company has demonstrated a significant growth trajectory, characterized by a **25%** increase in revenue and a **216%** surge in **Profit Before Tax (PBT)** for the most recent fiscal year. **Key Financial Metrics:** | Particulars (₹ in Crore) | FY 2024-25 | FY 2023-24 | Growth (%) | | :--- | :--- | :--- | :--- | | **Total Revenue** | **421.62** | **337.23** | **25.02%** | | **Profit Before Tax (PBT)** | **13.03** | **4.12** | **216.26%** | **Debt Management & Leverage:** The company is actively reducing its reliance on external debt. The **Gearing Ratio** has improved from **0.63** in 2022 to **0.42** in 2025. * **Total Equity (March 2025):** **₹34.72 Crore** * **Total Borrowings (March 2025):** **₹25.79 Crore** * **Term Loan:** A facility of **₹6.00 Crore** at an interest rate of **8.90%**, repayable in **78 monthly instalments**. * **Security:** Loans are secured by a first charge on **Stock and Book Debts** and an equitable mortgage of the factory land and machinery at **Sanand and Changodar**. --- ### **Supply Chain & Strategic Partnerships** Ambar Protein maintains a critical long-term supply arrangement with **Ankur Oil Industries** (a Group Partnership Firm) for the sale of refined edible oils in both loose and packaged forms. * **Current Agreement Term:** **April 1, 2024, to March 31, 2027**. * **Strategic Advantage:** This partnership ensures stable distribution channels and consistent off-take of refined products. --- ### **Market Outlook & Government Alignment** The company’s expansion is strategically aligned with the Government of India’s **National Mission on Edible Oils (NMEO)**, which targets **72%** domestic self-reliance by **2030-31** through a **₹10,103 crore** allocation. * **Capacity Expansion:** The Board approved a new **Sunflower Oil Refinery** with a capacity of **200 TPD (Tons Per Day)** in August 2023 to capture the growing demand for low-pungency cooking oils. * **Import Substitution:** The company identifies a significant opportunity in **Olive Oil** and **Canola Oil**, expecting exponential demand growth as domestically produced variants enter the Indian market. * **Raw Material Trends:** Cotton prices remain above the **Government Minimum Support Price (MSP)**, encouraging farmers to maintain high acreage, which secures the company's primary raw material source (cottonseed). --- ### **Risk Management & Regulatory Compliance** Ambar Protein operates under a robust **Risk Management Policy** overseen by a dedicated Treasury Department to navigate the volatile edible oil landscape. **Primary Risk Factors:** * **Commodity Volatility:** Prices are influenced by global factors such as the **Russia-Ukraine war**, **Middle East conflicts**, and climate events like **El Niño**. The company mitigates this through a mix of **spot buying** and **forward contracts**. * **Agro-Climatic Dependency:** Domestic yields are vulnerable to weather shocks and groundwater depletion. * **Regulatory Compliance:** The company adheres to the **Food Safety Standard Act (2006)** and **Legal Metrology Act (2009)**. * **Governance Note:** In **September 2024**, the company paid a fine of **₹21,240** for a late corporate governance filing. Additionally, an audit noted that the company needs to ensure **100%** of promoter shareholding is in dematerialized form per **SEBI LODR** regulations. **Financial Stability:** * The company reports **zero contingent liabilities**. * It has not been declared a **wilful defaulter** by any financial institution. * As of **March 31, 2025**, there are **no outstanding GDRs, ADRs, or Warrants**, ensuring no immediate risk of equity dilution.